Solution Spotlight: New .med URLs deliver value by indicatin...
Currently in a period of pre-registration that runs through August 2025, .med is a secure, premium TLD for the medical sector.
Taiho's late-stage Duchenne candidate fails trial
Taiho has suffered a blow to its near-term pipeline after a drug candidate for Duchenne muscular dystrophy (DMD) missed the mark in a phase 3 trial.
Boehringer raises hope of oral drug for diabetic eye disease
Boehringer has started a phase 2 trial of an oral therapy that could help people with diabetic macular oedema avoid regular injections into the eye.
Unicorns, AI, and the future of health: Highlights from HLTH...
Deep Dive editor Eloise McLennan debriefs on the key themes, hot topics, and hallway conversations that shaped the HLTH event in Amsterdam.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
The World's Definitive Degrader & Proximity-Based Drugs Even...
The 8th Annual TPD & Induced Proximity Summit is the world’s largest and longest-standing forum for proximity-based modalities
Welcome to the 7th Exosome-Based Therapeutic Development Sum...
Accelerate Therapeutic Efficacy & Delivery Potential of Exosomes & EVs
Welcome to the 10th CDD for Biologics Summit
Accelerate Therapeutic Efficacy & Delivery Potential of Exosomes & EVs
The Inaugural Multi-Omics Based Drug Discovery & Development
The Industry-Led Forum Dedicated to Expanding the Applications of Multi-Omics Across Therapeutic Development
2nd Translational Digital Pathology & AI Summit
Don’t miss the return of this event, uniting 60+ leading biopharma pioneers driving the adoption and utilization of digital pathology